WM alterations in AD have been considered the result of cerebrovascular dysfunction [138, 139], axonopathy linked to retrograde neuronal tau deposition [100, 101, 102], or homeostatic responses to age‐related myelin breakdown [140]. The gene discussed is MAPT; the disease is Alzheimer disease.